Cue Biopharma Inc.
CUE
|
|
|
|
Trading Volume | 27,650 |
|
3.10 - 0.60 |
Market Cap Full | $ 32.5M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 28.7% | -27.7% | 25.3% | -57% |
Q2 | - | -27.4% | 2.2% | -49.1% |
Q3 | - | -20% | -37% | -10.4% |
Q4 | - | -41.9% | 25.4% | 27.8% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
28.7 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
- | -21.4 | -8 | -17.8 | 3.8 | -15.3 | -34.8 | -20 | - | - | - | -10 |
2023 | |||||||||||
20 | -18.1 | 27.5 | 21.3 | -7.6 | -8.8 | 4.7 | -29.1 | -15.1 | -8.7 | 19.1 | 5.6 |
2022 | |||||||||||
-35 | -21.5 | -15.7 | -18.9 | -2.4 | -35.7 | 9.2 | 8.1 | -24.2 | 19.3 | 45.1 | -26.2 |
2021 | |||||||||||
8.3 | -3 | -7.7 | 0.3 | 17.8 | -18.8 | -10.6 | 15.1 | 21.5 | -16.2 | -1.5 | -5.5 |
2020 | |||||||||||
-5.4 | 11.1 | -15.3 | 80.3 | 8.2 | -11.5 | -22.9 | -5.5 | -15.8 | -26 | 25.5 | -10.6 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.3 | -0.4 | -0.4 | -0.5 |
Q2 | -0.3 | -0.4 | -0.3 | -0.4 |
Q3 | -0.2 | -0.3 | -0.4 | -0.3 |
Q4 | 0 | -0.4 | -0.3 | -0.4 |
A | -0.82 | -1.5 | -1.4 | -1.6 |